Re:BioNTech CEO applies Covid-19 vaccine's mRNA tech to mult...
by usehackernews on Wednesday January 13, 2021 @11:05AM
(#25763818)
I state that CRISPR benefits researchers. However, that is still a niche benefit relative to the long term societal benefits we anticipate from CRISPR.
[ Parent
| on HN ]
There are no comments on this comment yet.